Sam Brusco, Associate Editor07.11.22
Integrated medical device contract manufacturer Biomerics has acquired Dependable Plastics and created a new division —Biomerics Interventional Medical Plastics (IMP) Division.
The company’s IMP division has operations in Fairfield, Calif., and Salt Lake City and is a full-service plastics component distributor to the interventional device market with focus on robotic-assisted surgery.
Dependable Plastics is an industry leader in advanced thermoforming, liquid cast resin molding, and additive manufacturing. Combined with Biomerics’ injection molding operations, the capabilities create a full-service plastics component supplier to interventional markets.
"In support of our leading customers, Biomerics is excited to launch our Interventional Medical Plastics Division," Travis Sessions, CEO of Biomerics told the press. "This acquisition expands our plastic component capabilities for the interventional robotic surgical market. We are excited to welcome the Dependable Plastics employees to the Biomerics team."
Biomerics IMP offers plastic component technologies including liquid cast resin, advanced thermoforming, injection molding, and additive (printed part) manufacturing. The division also offers pad printing, painting, shielding, and sub-assemblies. Biomerics provides design, development, and production services to help customers develop next gen robot-assisted surgery systems.
Biomerics IMP will be led by Brett Poole who will transfer responsibilities from the founders over the rest of the year. "I look forward to joining Biomerics to lead the Dependable Plastics team," stated Brett Poole, President of Biomerics IMP. "I look forward to continuing the 40-year history of excellence and integrating these new capabilities into Biomerics.
The company’s IMP division has operations in Fairfield, Calif., and Salt Lake City and is a full-service plastics component distributor to the interventional device market with focus on robotic-assisted surgery.
Dependable Plastics is an industry leader in advanced thermoforming, liquid cast resin molding, and additive manufacturing. Combined with Biomerics’ injection molding operations, the capabilities create a full-service plastics component supplier to interventional markets.
"In support of our leading customers, Biomerics is excited to launch our Interventional Medical Plastics Division," Travis Sessions, CEO of Biomerics told the press. "This acquisition expands our plastic component capabilities for the interventional robotic surgical market. We are excited to welcome the Dependable Plastics employees to the Biomerics team."
Biomerics IMP offers plastic component technologies including liquid cast resin, advanced thermoforming, injection molding, and additive (printed part) manufacturing. The division also offers pad printing, painting, shielding, and sub-assemblies. Biomerics provides design, development, and production services to help customers develop next gen robot-assisted surgery systems.
Biomerics IMP will be led by Brett Poole who will transfer responsibilities from the founders over the rest of the year. "I look forward to joining Biomerics to lead the Dependable Plastics team," stated Brett Poole, President of Biomerics IMP. "I look forward to continuing the 40-year history of excellence and integrating these new capabilities into Biomerics.